Clinical Trial

Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2023 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, open-label, randomized controlled, prospective clinical study to evaluate the efficacy and safety of Huaier Granules in patients with advanced breast cancer without visceral metastasis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-05-12.
Trial Details
NCT Number NCT05860907
Lead Sponsor Fudan University
Collaborators: LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology
Conditions Breast Cancer Stage IV
Enrollment 384 participants
Start Date 2023-10
Primary Completion 2025-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2023-09-26